Pigment Dispersion Syndrome and Pigmentary Glaucoma
Chat Highlights
May 3, 2006
Norma Devine, Editor
On Wednesday, May 3, 2006, Dr.
Tricia Thomas, a glaucoma specialist at Wills, and the
glaucoma chat group discussed "Pigment Dispersion Syndrome and
Pigmentary Glaucoma."
Moderator: We'd
like to give a big, warm welcome tonight to Dr. Tricia Lennox
Thomas. Dr. Thomas graduated cum laude (Molecular Biology)
from Princeton University, served a fellowship with Dr. Ritch
at NYE&E before her residency at Wills, and joined the staff
at Wills last January. Thank you so much for being here
tonight.
Dr. Tricia Thomas: Thank
you. I’m glad to be able to be here.
Moderator:
Our topic tonight is Pigment Dispersion Syndrome (PDS) and Pigmentary
Glaucoma (PG). Dr. Thomas, since you served a fellowship
with Dr. Robert Ritch, you know his Rule #1: "Anyone
with open-angle glaucoma under the age of 50 has pigmentary glaucoma
until proved otherwise." Why is that his Rule #1?
Dr. Tricia Thomas:
Dr. Ritch believes PDS is missed frequently clinically.
The typical triad for PDS is pigmentation on the cornea (called
Krukenberg spindles), transillumination defects, and dense pigmentation
in the trabecular meshwork. You won’t see all of these
signs in many patients unless you look carefully.
P: I thought it
was easy to see the pigment in the trabecular meshwork.
Dr. Tricia Thomas:
It is easy to see the pigmentation. However, you have to
perform gonioscopy.
Moderator: Isn't that part of a standard examination?
Dr. Tricia Thomas: It is not part of a standard eye exam, but
should be performed on anyone who is suspicious for glaucoma.
P: What does gonioscopy involve?
Dr. Tricia Thomas: In gonioscopy, a special lens is used to look
at the drainage structure of the eye.
P: What are the risk factors for pigmentary glaucoma?
Dr. Tricia Thomas: That type of glaucoma is hereditary and is
more common in myopic (near-sighted) individuals.
P: Some glaucoma patients say they have both primary open-angle
glaucoma and PG. Isn't PG one of the many types of open-angle
glaucoma?
Dr. Tricia Thomas: PG is a type of open-angle glaucoma.
Moderator: Does PDS always lead to PG?
Dr. Tricia Thomas: No, not all individuals with PDS get PG.
P: What other secondary glaucomas could be mistaken for PG?
Dr. Tricia Thomas: PDS is characterized by a disruption of the
iris pigment epithelium. That deposits the pigment in various
parts of the front of the eye, including the drainage structure,
which can make the eye pressure go up.
P: When is the pigment released?
Dr. Tricia Thomas:
It’s released early in the process, from age 20 to 40. As
we get older, however, we do not make as much pigment and the
pigment can be absorbed, making it look more like open-angle glaucoma.
The optic nerve shows damage.
P: Is the treatment different for pigmentary glaucoma than it
is for open-angle glaucoma?
Dr. Tricia Thomas: Often the treatment is the same for PDS/PG
and other open-angle glaucomas.
P: Would it be fairly easy for an ophthalmologist to originally
diagnose pigmentary and then, a few months later, decide it is
open-angle glaucoma? (That happened to me.)
Dr. Tricia Thomas: Yes, that could happen. In fact, I saw someone
today who was diagnosed years ago with PDS and was then recently
told it was open-angle glaucoma.
P: Why is pigment normally released?
Dr. Tricia Thomas: Pigment is not normally released. In this condition,
the iris is bowed posteriorly and rubs on the zonules, which are
small fibers attached to the lens.
P. Are there anatomical differences in the angles of patients
with PDS and PG?
Dr. Tricia Thomas:
PDS and PG patients have a larger iris than normal individuals,
and the insertion of the iris is more posterior (located further
back in the eye). This anatomical difference allows the
iris to rub on the zonules.
P: Why do
we make less pigment as we get older? Is it like graying hair?
And at about the same age (say 50's)?
Dr. Tricia Thomas:
As the iris rubs, pigment is dispersed. As we get older,
the lens of the eye gets larger, so there is less room for the
iris to rub. In addition, when we are young, the iris curves
backward during accommodation (near vision). As we get older,
however, we are not able to accommodate as well.
P: If I understand this form of glaucoma correctly, wouldn't ALT
(argon laser trabeculoplasty) or SLT (selective laser trabeculoplasty)
be effective for patients with PG under age 50?
Dr. Tricia Thomas:
The treatment for PDS and PG is glaucoma drops first. However,
ALT and SLT are also effective.
P: My pigmentary
glaucoma is being treated with Xalatan. I have a problem,
not so much with my individual treatment, as with the paradigm
of treating the symptom but not the cause, i.e., lowering the
pressure, but not addressing the shedding of pigment. Since
I have retinal problems that put me at risk for retinal detachment,
I wouldn't consider a miotic such as pilocarpine. I've seen
papers from European researchers indicating the use of Dapiprazole,
a miotic that acts only on the iris dilator muscle, causing miosis
without traction on the retina. Since that sounds like such
an intuitive approach, why haven't more researchers picked up
on it? My clinician thinks there's not enough experience
with Dapiprazole over the long term, although the people publishing
what little data exist say it's well tolerated. Your thoughts,
please.
Dr. Tricia Thomas:
Dapiprazole is used in Europe and is effective at straightening
the iris to make it flat and not release more pigment. This
medicine constricts the pupil and pulls the peripheral iris away
from the zonules. The problem is that it is poorly tolerated due
to burning and redness.
P: The reason
I'd prefer to address the shedding of pigment is the fear that
even once pigment release has abated, the trabecular meshwork
has been irreparably damaged, so that even in the absence of further
pigment release, there is lifelong dysfunction of the trabecular
meshwork. Doesn't that occur frequently?
Dr. Tricia Thomas:
The peripheral laser iridotomy is likely to be more effective
early in the disease process before a lot of the pigment has been
dispersed. Once the optic nerve is damaged, the iridotomy
will not be as effective.
P: Do you
think that head movement in certain types of exercise is what
causes the associated pigment showers, or could it be due to the
elevation of the ocular pulse, irrespective of movement? I
saw a paper once that documented pigment release in response to
exercise on stationary bikes. The researchers postulated
that it was the latter (elevated ocular pulse) that resulted in
pigment release, either from pupillary block, or reverse pupillary
block. Obviously, everybody else in the literature says
jarring head movements must be avoided. How do you counsel
your PG patients regarding exercise?
Dr. Tricia Thomas:
Some patients with PDS or PG have pigment release during exercise
and will have blurry vision or elevated eye pressure. I
have not read the article on elevated ocular pulse. However,
it is more likely due to the reverse pupillary block (from the
posteriorly bowed iris). In patients with this problem, a drop
of pilocarpine before exercise can relieve that, as pilocarpine
is a miotic, constricts the pupil, and eliminates the pupillary
block.
P: What indicates that PDS or PG is "burned out" or
almost resolved?
Dr. Tricia Thomas: There is a regression phase when pigment is
no longer released, the corneal pigmentation clears, transillumination
defects in the iris can disappear, and the pigmentation in the
drain clears first in the inferior drain.
P: Do blue-eyed people have fewer problems with pigmentary glaucoma?
Dr. Tricia Thomas: Actually, it is the iris pigment epithelium
behind the blue part of the iris that is disrupted and deposited
throughout the eye. It is easier to see this condition in blue-eyed
individuals.
P: So the epithelial cells get rubbed off and drain into the trabecular
meshwork, where everything dissolves but the pigment?
Dr. Tricia Thomas:
Correct. The drain gets clogged with this pigment. Think
of it as throwing coffee grounds into the sink. If there
is too much, the sink won't drain.
P: We have
not had a chat about PG and PDS since 2004. Have there been
long-term clinical trials since then showing that iridotomy will
prevent the eventual increase of IOP in patients with PDS?
Dr. Tricia Thomas:
We still need a long-term study. The American Glaucoma Society
published one study, in which all glaucoma specialists were asked
to submit results from their patients. Only 60 were submitted,
which was not enough to determine if it was really effective.
Moderator:
Dr. Thomas, we've really enjoyed having you here tonight. Thanks
so much. Your answers have been helpful and informative.
We hope you will come again.
On May 10, Dr. Werner discussed "Glaucoma Terminology" in the
Chat room. Click here for highlights
of that meeting.
Click here for the most recent
glaucoma chat highlights and links to the chat archives.
Click here for
upcoming glaucoma chat events.
|